The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP

References

Arens, J., Duong, T.T., and Dehmelt, L. (2013). A morphometric screen identifies specific roles for microtubule-regulating genes in neuronal development of P19 stem cells. PLoS One 8, e79796.10.1371/journal.pone.0079796Suche in Google Scholar

Bassan, M., Zamostiano, R., Davidson, A., Pinhasov, A., Giladi, E., Perl, O., Bassan, H., Blat, C., Gibney, G., Glazner, G., et al. (1999). Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J. Neurochem. 72, 1283–1293.10.1046/j.1471-4159.1999.0721283.xSuche in Google Scholar

Ben-Ze’ev, A., Farmer, S.R., and Penman, S. (1979). Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell 17, 319–325.10.1016/0092-8674(79)90157-0Suche in Google Scholar

Brenneman, D.E. and Gozes, I. (1996). A femtomolar-acting neuroprotective peptide. J. Clin. Invest. 97, 2299–2307.10.1172/JCI118672Suche in Google Scholar PubMed PubMed Central

Brenneman, D.E., Hauser, J., Neale, E., Rubinraut, S., Fridkin, M., Davidson, A., and Gozes, I. (1998). Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides. J. Pharmacol. Exp. Ther. 285, 619–627.Suche in Google Scholar

Brown, B.P., Kang, S.C., Gawelek, K., Zacharias, R.A., Anderson, S.R., Turner, C.P., and Morris, J.K. (2015). In vivo and in vitro ketamine exposure exhibits a dose-dependent induction of activity-dependent neuroprotective protein in rat neurons. Neuroscience 290, 31–40.10.1016/j.neuroscience.2014.12.076Suche in Google Scholar PubMed

Chierchia, L., Tussellino, M., Guarino, D., Carotenuto, R., DeMarco, N., Campanella, C., Biffo, S., and Vaccaro, M.C. (2014). Cytoskeletal proteins associate with components of the ribosomal maturation and translation apparatus in Xenopus stage I oocytes. Zygote 1–14.Suche in Google Scholar

Coe, B.P., Witherspoon, K., Rosenfeld, J.A., van Bon, B.W., Vulto-van Silfhout, A.T., Bosco, P., Friend, K.L., Baker, C., Buono, S., Vissers, L.E., et al. (2014). Refining analyses of copy number variation identifies specific genes associated with developmental delay. Nat. Genet. 46, 1063–1071.10.1038/ng.3092Suche in Google Scholar PubMed PubMed Central

De Rubeis, S., He, X., Goldberg, A.P., Poultney, C.S., Samocha, K., Cicek, A.E., Kou, Y., Liu, L., Fromer, M., Walker, S., et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215.10.1038/nature13772Suche in Google Scholar PubMed PubMed Central

Dresner, E., Agam, G., and Gozes, I. (2011). Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: Deregulation in schizophrenia. Eur. Neuropsychopharmacol. 21, 355–361.10.1016/j.euroneuro.2010.06.004Suche in Google Scholar PubMed

Dresner, E., Malishkevich, A., Arviv, C., Leibman Barak, S., Alon, S., Ofir, R., Gothilf, Y., and Gozes, I. (2012). Novel evolutionary-conserved role for the activity-dependent neuroprotective protein (ADNP) family that is important for erythropoiesis. J. Biol. Chem. 287, 40173–40185.10.1074/jbc.M112.387027Suche in Google Scholar PubMed PubMed Central

Fernandez-Montesinos, R., Torres, M., Baglietto-Vargas, D., Gutierrez, A., Gozes, I., Vitorica, J., and Pozo, D. (2010). Activity-dependent neuroprotective protein (ADNP) expression in the amyloid precursor protein/presenilin 1 mouse model of Alzheimer’s disease. J. Mol. Neurosci. 41, 114–120.10.1007/s12031-009-9300-xSuche in Google Scholar PubMed

Furman, S., Steingart, R.A., Mandel, S., Hauser, J.M., Brenneman, D.E., and Gozes, I. (2004). Subcellular localization and secretion of activity-dependent neuroprotective protein in astrocytes. Neuron. Glia Biol. 1, 193–199.10.1017/S1740925X05000013Suche in Google Scholar

Furman, S., Hill, J.M., Vulih, I., Zaltzman, R., Hauser, J.M., Brenneman, D.E., and Gozes, I. (2005). Sexual dimorphism of activity-dependent neuroprotective protein in the mouse arcuate nucleus. Neurosci. Lett. 373, 73–78.10.1016/j.neulet.2004.09.077Suche in Google Scholar

Giladi, E., Hill, J.M., Dresner, E., Stack, C.M., and Gozes, I. (2007). Vasoactive intestinal peptide (VIP) regulates activity-dependent neuroprotective protein (ADNP) expression in vivo. J. Mol. Neurosci. 33, 278–283.10.1007/s12031-007-9003-0Suche in Google Scholar

Gkogkas, C.G., Khoutorsky, A., Ran, I., Rampakakis, E., Nevarko, T., Weatherill, D.B., Vasuta, C., Yee, S., Truitt, M., Dallaire, P., et al. (2013). Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493, 371–377.10.1038/nature11628Suche in Google Scholar

Glowa, J.R., Panlilio, L.V., Brenneman, D.E., Gozes, I., Fridkin, M., and Hill, J.M. (1992). Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res. 570, 49–53.10.1016/0006-8993(92)90562-NSuche in Google Scholar

Gozes, I., Meltzer, E., Rubinrout, S., Brenneman, D.E., and Fridkin, M. (1989). Vasoactive intestinal peptide potentiates sexual behavior: inhibition by novel antagonist. Endocrinology 125, 2945–2949.10.1210/endo-125-6-2945Suche in Google Scholar PubMed

Gozes, I., Glowa, J., Brenneman, D.E., McCune, S.K., Lee, E., and Westphal, H. (1993). Learning and sexual deficiencies in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J. Mol. Neurosci. 4, 185–193.10.1007/BF02782501Suche in Google Scholar PubMed

Gozes, I., Iram, T., Maryanovsky, E., Arviv, C., Rozenberg, L., Schirer, Y., Giladi, E., and Furman-Assaf, S. (2014). Novel tubulin and tau neuroprotective fragments sharing structural similarities with the drug candidate NAP (Davuentide). J. Alzheimers Dis. 40 (Suppl 1), S23–36.10.3233/JAD-131664Suche in Google Scholar PubMed

Gozes, I., Yeheskel, A., and Pasmanik-Chor, M. (2015). Activity-dependent neuroprotective protein (ADNP): a case study for highly conserved chordata-specific genes shaping the brain and mutated in cancer. J. Alzheimers Dis. 45, 57–73.10.3233/JAD-142490Suche in Google Scholar PubMed

Helsmoortel, C., Vulto-van Silfhout, A.T., Coe, B.P., Vandeweyer, G., Rooms, L., van den Ende, J., Schuurs-Hoeijmakers, J.H., Marcelis, C.L., Willemsen, M.H., Vissers, L.E., et al. (2014). A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat. Genet. 46, 380–384.10.1038/ng.2899Suche in Google Scholar PubMed PubMed Central

Hill, J.M., Hauser, J.M., Sheppard, L.M., Abebe, D., Spivak-Pohis, I., Kushnir, M., Deitch, I., and Gozes, I. (2007). Blockage of VIP during mouse embryogenesis modifies adult behavior and results in permanent changes in brain chemistry. J. Mol. Neurosci. 31, 183–200.10.1385/JMN:31:03:185Suche in Google Scholar

Holtser-Cochav, M., Divinski, I., and Gozes, I. (2006). Tubulin is the target binding site for NAP-related peptides: ADNF-9, D-NAP, and D-SAL. J. Mol. Neurosci. 28, 303–307.10.1385/JMN:28:3:303Suche in Google Scholar

Jarskog, L.F., Dong, Z., Kangarlu, A., Colibazzi, T., Girgis, R.R., Kegeles, L.S., Barch, D.M., Buchanan, R.W., Csernansky, J.G., Goff, D.C., et al. (2013). Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology 38, 1245–1252.10.1038/npp.2013.23Suche in Google Scholar

Javitt, D.C., Buchanan, R.W., Keefe, R.S., Kern, R., McMahon, R.P., Green, M.F., Lieberman, J., Goff, D.C., Csernansky, J.G., McEvoy, J.P., et al. (2012). Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr. Res. 136, 25–31.10.1016/j.schres.2011.11.001Suche in Google Scholar

Jaworski, J., Kapitein, L.C., Gouveia, S.M., Dortland, B.R., Wulf, P.S., Grigoriev, I., Camera, P., Spangler, S.A., Di Stefano, P., Demmers, J., et al. (2009). Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity. Neuron 61, 85–100.10.1016/j.neuron.2008.11.013Suche in Google Scholar

Jouroukhin, Y., Ostritsky, R., Assaf, Y., Pelled, G., Giladi, E., and Gozes, I. (2013). NAP (davunetide) modifies disease progression in a mouse model of severe neurodegeneration: protection against impairments in axonal transport. Neurobiol. Dis. 56C, 79–94.10.1016/j.nbd.2013.04.012Suche in Google Scholar

Kushnir, M., Dresner, E., Mandel, S., and Gozes, I. (2008). Silencing of the ADNP-family member, ADNP2, results in changes in cellular viability under oxidative stress. J. Neurochem. 105, 537–545.10.1111/j.1471-4159.2007.05173.xSuche in Google Scholar

Luo, S., and Rubinsztein, D.C. (2013). BCL2L11/BIM: a novel molecular link between autophagy and apoptosis. Autophagy 9, 104–105.10.4161/auto.22399Suche in Google Scholar

Magen, I., and Gozes, I. (2013). Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP). Neuropeptides 47, 489–495.10.1016/j.npep.2013.10.011Suche in Google Scholar

Magen, I., and Gozes, I. (2014). Davunetide: Peptide therapeutic in neurological disorders. Curr. Med. Chem. 21, 2591–2598.10.2174/0929867321666140217124945Suche in Google Scholar

Malishkevich, A., Amram, N., Hacohen-Kleiman, G., Magen, I., Giladi, E., and Gozes, I. (2015). Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer’s pathologies. Transl. Psychiatry 5, e501.10.1038/tp.2014.138Suche in Google Scholar

Mandel, S. and Gozes, I. (2007). Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. J. Biol. Chem. 282, 34448–34456.10.1074/jbc.M704756200Suche in Google Scholar

Mandel, S., Rechavi, G., and Gozes, I. (2007). Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Dev. Biol. 303, 814–824.10.1016/j.ydbio.2006.11.039Suche in Google Scholar

Mandel, S., Spivak-Pohis, I., and Gozes, I. (2008). ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. J. Mol. Neurosci. 35, 127–141.10.1007/s12031-007-9013-ySuche in Google Scholar

Matsuoka, Y., Gray, A.J., Hirata-Fukae, C., Minami, S.S., Waterhouse, E.G., Mattson, M.P., LaFerla, F.M., Gozes, I., and Aisen, P.S. (2007). Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer’s disease at early pathological stage. J. Mol. Neurosci. 31, 165–170.10.1385/JMN/31:02:165Suche in Google Scholar

Matsuoka, Y., Jouroukhin, Y., Gray, A.J., Ma, L., Hirata-Fukae, C., Li, H.F., Feng, L., Lecanu, L., Walker, B.R., Planel, E., et al. (2008). A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer’s disease. J. Pharmacol. Exp. Ther. 325, 146–153.10.1124/jpet.107.130526Suche in Google Scholar PubMed

Merenlender-Wagner, A., Pikman, R., Giladi, E., Andrieux, A., and Gozes, I. (2010). NAP (davunetide) enhances cognitive behavior in the STOP heterozygous mouse – a microtubule-deficient model of schizophrenia. Peptides 31, 1368–1373.10.1016/j.peptides.2010.04.011Suche in Google Scholar PubMed

Merenlender-Wagner, A., Shemer, Z., Touloumi, O., Lagoudaki, R., Giladi, E., Andrieux, A., Grigoriadis, N.C., and Gozes, I. (2014). New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia. Autophagy 10, 2324–2332.10.4161/15548627.2014.984274Suche in Google Scholar PubMed PubMed Central

Merenlender-Wagner, A., Malishkevich, A., Shemer, Z., Udawela, M., Gibbons, A., Scarr, E., Dean, B., Levine, J., Agam, G., and Gozes, I. (2015). Autophagy has a key role in the pathophysiology of schizophrenia. Mol. Psychiatry 20, 126–132.10.1038/mp.2013.174Suche in Google Scholar PubMed PubMed Central

Morimoto, B.H., Schmechel, D., Hirman, J., Blackwell, A., Keith, J., and Gold, M. (2013). A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 35, 325–336.10.1159/000348347Suche in Google Scholar PubMed

Mosch, K., Franz, H., Soeroes, S., Singh, P.B., and Fischle, W. (2011). HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats. PLoS One 6, e15894.10.1371/journal.pone.0015894Suche in Google Scholar PubMed PubMed Central

O’Roak, B.J., Vives, L., Fu, W., Egertson, J.D., Stanaway, I.B., Phelps, I.G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012a). Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338, 1619–1622.10.1126/science.1227764Suche in Google Scholar

O’Roak, B.J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B.P., Levy, R., Ko, A., Lee, C., Smith, J.D., et al. (2012b). Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485, 246–250.10.1038/nature10989Suche in Google Scholar

Oz, S., Ivashko-Pachima, Y., and Gozes, I. (2012). The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities. PLoS One 7, e51458.10.1371/journal.pone.0051458Suche in Google Scholar

Oz, S., Kapitansky, O., Ivashco-Pachima, Y., Malishkevich, A., Giladi, E., Skalka, N., Rosin-Arbesfeld, R., Mittelman, L., Segev, O., Hirsch, J.A., et al. (2014). The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Mol. Psychiatry 19, 1115–1124.10.1038/mp.2014.97Suche in Google Scholar

Pescosolido, M.F., Schwede, M., Johnson Harrison, A., Schmidt, M., Gamsiz, E.D., Chen, W.S., Donahue, J.P., Shur, N., Jerskey, B.A., Phornphutkul, C., et al. (2014). Expansion of the clinical phenotype associated with mutations in activity-dependent neuroprotective protein. J. Med. Genet. 51, 587–589.10.1136/jmedgenet-2014-102444Suche in Google Scholar

Pinhasov, A., Mandel, S., Torchinsky, A., Giladi, E., Pittel, Z., Goldsweig, A.M., Servoss, S.J., Brenneman, D.E., and Gozes, I. (2003). Activity-dependent neuroprotective protein: a novel gene essential for brain formation. Brain Res. Dev. Brain Res. 144, 83–90.10.1016/S0165-3806(03)00162-7Suche in Google Scholar

Quraishe, S., Cowan, C.M., and Mudher, A. (2013). NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy. Mol. Psychiatry 18, 834–842.10.1038/mp.2013.32Suche in Google Scholar PubMed PubMed Central

Schirer, Y., Malishkevich, A., Ophir, Y., Lewis, J., Giladi, E., and Gozes, I. (2014). Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation. PLoS One 9, e87383.10.1371/journal.pone.0087383Suche in Google Scholar PubMed PubMed Central

Shiryaev, N., Jouroukhin, Y., Giladi, E., Polyzoidou, E., Grigoriadis, N.C., Rosenmann, H., and Gozes, I. (2009). NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model. Neurobiol. Dis. 34, 381–388.10.1016/j.nbd.2009.02.011Suche in Google Scholar PubMed

Sudo, H. and Baas, P.W. (2011). Strategies for diminishing katanin-based loss of microtubules in tauopathic neurodegenerative diseases. Hum. Mol. Genet. 20, 763–778.10.1093/hmg/ddq521Suche in Google Scholar PubMed PubMed Central

Vandeweyer, G., Helsmoortel, C., Van Dijck, A., Vulto-van Silfhout, A.T., Coe, B.P., Bernier, R., Gerdts, J., Rooms, L., van den Ende, J., Bakshi, M., et al. (2014). The transcriptional regulator ADNP links the BAF (SWI/SNF) complexes with autism. Am. J. Med. Genet. C Semin. Med. Genet. 166C, 315–326.10.1002/ajmg.c.31413Suche in Google Scholar PubMed PubMed Central

Vulih-Shultzman, I., Pinhasov, A., Mandel, S., Grigoriadis, N., Touloumi, O., Pittel, Z., and Gozes, I. (2007). Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J. Pharmacol. Exp. Ther. 323, 438–449.10.1124/jpet.107.129551Suche in Google Scholar PubMed

Yang, M.H., Yang, Y.H., Lu, C.Y., Jong, S.B., Chen, L.J., Lin, Y.F., Wu, S.J., Chu, P.Y., Chung, T.W., and Tyan, Y.C. (2012). Activity-dependent neuroprotector homeobox protein: a candidate protein identified in serum as diagnostic biomarker for Alzheimer’s disease. J. Proteomics 75, 3617–3629.10.1016/j.jprot.2012.04.017Suche in Google Scholar PubMed

Zamostiano, R., Pinhasov, A., Gelber, E., Steingart, R.A., Seroussi, E., Giladi, E., Bassan, M., Wollman, Y., Eyre, H.J., Mulley, J.C., et al. (2001). Cloning and characterization of the human activity-dependent neuroprotective protein. J. Biol. Chem. 276, 708–714.10.1074/jbc.M007416200Suche in Google Scholar PubMed

Zusev, M. and Gozes, I. (2004). Differential regulation of activity-dependent neuroprotective protein in rat astrocytes by VIP and PACAP. Regul. Pept. 123, 33–41.10.1016/j.regpep.2004.05.021Suche in Google Scholar PubMed